Postconditioning Inhibits Mitochondrial Permeability Transition

Author:

Argaud Laurent1,Gateau-Roesch Odile1,Raisky Olivier1,Loufouat Joseph1,Robert Dominique1,Ovize Michel1

Affiliation:

1. From INSERM E 0226, Université Claude Bernard Lyon I (L.A., O.G.-R., O.R., J.L., M.O.), and Département d’Urgence et de Réanimation Médicale, Hospices Civils de Lyon (L.A., D.R.), Lyon, France.

Abstract

Background— Brief periods of ischemia performed just at the time of reperfusion can reduce infarct size, a phenomenon called “postconditioning.” After reflow, opening of the mitochondrial permeability transition pore (mPTP) has been involved in lethal reperfusion injury. We hypothesized that postconditioning may modulate mPTP opening. Methods and Results— Anesthetized open-chest rabbits underwent 30 minutes of ischemia and 4 hours of reperfusion. Control hearts underwent no additional intervention. Postconditioning consisted of 4 episodes of 1 minute of coronary occlusion and 1 minute of reperfusion performed after 1 minute of reflow after the prolonged ischemia. Preconditioning consisted of 5 minutes of ischemia and 5 minutes of reperfusion before the 30-minute ischemia. An additional group of rabbits received 5 mg/kg IV of NIM811, a specific inhibitor of the mPTP, 1 minute before reperfusion. Infarct size was assessed by triphenyltetrazolium staining. Mitochondria were isolated from the risk region myocardium, and Ca 2+ -induced mPTP opening was assessed by use of a potentiometric method. Postconditioning, preconditioning, and NIM811 significantly limited infarct size, which averaged 29±4%, 18±4%, and 20±4% of the risk region, respectively, versus 61±6% in controls ( P ≤0.001 versus control). The Ca 2+ load required to open the mPTP averaged 41±4, 47±5, and 67±9 μmol/L CaCl 2 per mg of mitochondrial proteins in postconditioning, preconditioning, and NIM811, respectively, significantly higher than the value of 16±4 μmol/L per mg in controls ( P ≤0.05). Conclusions— Postconditioning inhibits opening of the mPTP and provides a powerful antiischemic protection.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3